Standout Papers

Phase II Trial of Gefitinib in Recurrent Glioblastoma 2003 2026 2010 2018 546
  1. Phase II Trial of Gefitinib in Recurrent Glioblastoma (2003)
    Jeremy N. Rich, David A. Reardon et al. Journal of Clinical Oncology

Immediate Impact

2 by Nobel laureates 25 from Science/Nature 81 standout
Sub-graph 1 of 21

Citing Papers

The integrated stress response: From mechanism to disease
2020 StandoutScience
The biology and management of non-small cell lung cancer
2018 StandoutNature
2 intermediate papers

Works of James C. Kao being referenced

Phase II Trial of Gefitinib in Recurrent Glioblastoma
2003 Standout
Bimanual Coordination Dynamics in Adults with Down Syndrome
2002

Author Peers

Author Last Decade Papers Cites
James C. Kao 41 23 7 353 236 10 631
Karine Michaud 27 2 257 120 15 519
Paula Ravin 32 2 193 282 15 690
Jumpei Homma 7 235 292 15 714
Teresa Pujol 12 396 147 21 592
Hinke F. van Thuijl 6 1 345 194 11 666
Nicholas G. Avgeropoulos 5 1 409 226 17 672
Scott Peak 3 2 431 130 9 632
E. Q. Lee 4 1 317 241 8 562
Tessa Johung 30 337 262 8 719
Eduard B. Dinca 3 1 278 244 17 642

All Works

Loading papers...

Rankless by CCL
2026